Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
4DMedicalASX:4DX +1.47%71 Days Sales Outstanding is 115.15 as of Jun. 2026, which is 16% below its 10-year median of 136.76. GuruFocus rates ASX:4DX with a GF Score™ of 71/100 and a GF Value™ of A$2.34 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 810 Medical Devices & Instruments companies, 4DMedical ranks worse than 83.33% on this metric.
4DMedical's average Accounts Receivable for the
six
months ended in Jun. 2026 was A$2.63 Mil. 4DMedical's Revenue for the
six
months ended in Jun. 2026 was A$4.17 Mil.
Hence, 4DMedical's Days Sales Outstanding for the
six
months ended in Jun. 2026 was 115.15.
The historical rank and industry rank for 4DMedical's Days Sales Outstanding or its related term are showing as below:
ASX:4DX'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 77.38 Med: 136.76 Max: 1766.11
Current: 112.57
During the past 7 years, 4DMedical's highest Days Sales Outstanding was 1766.11. The lowest was 77.38. And the median was 136.76.
ASX:4DX's Days Sales Outstanding is ranked worse than 83.33% of 810
companies
in the Medical Devices & Instruments industry
Industry Median: 65.25
vs ASX:4DX: 112.57
4DMedical's Days Sales Outstanding
increased
from Jun. 2025 (71.66) to Jun. 2026 (115.15).
4DMedical (ASX:4DX) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
4DMedical Days Sales Outstanding Related Terms
4DMedical Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for 4DMedical's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ASX:4DX vs ABT, SYK, MDT: Days Sales Outstanding Comparison
For the Medical Devices subindustry, 4DMedical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
4DMedical Days Sales Outstanding vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, 4DMedical's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where 4DMedical's Days Sales Outstanding falls into.
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a Days Sales Outstanding of 115.15 mean?
4DMedical (ASX:4DX) has a Days Sales Outstanding of 115.15 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on 4DMedical and its competitors. This is 16% below median its historical median of 136.76. Over the past decade, 4DMedical's Days Sales Outstanding has ranged from 77.38 to 1,766.11. According to the industry distribution chart, 4DMedical ranks #675 out of 810 companies in the Medical Devices & Instruments industry, placing it in the top 83.3%.
Is 4DMedical's Days Sales Outstanding too high?
4DMedical's current Days Sales Outstanding of 115.15 is 16% below median its 10-year median of 136.76. Over the past 10 years, this metric has ranged from a low of 77.38 to a high of 1,766.11. The Medical Devices & Instruments industry median Days Sales Outstanding is 65.25. 4DMedical's value of 115.15 is 76.5% above this industry median. Based on the distribution chart, 4DMedical ranks #675 out of 810 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, 4DMedical has a GF Score™ of 71/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does 4DMedical's Days Sales Outstanding compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, 4DMedical ranks #675 out of 810 companies for Days Sales Outstanding. This places 4DMedical in the lower half of its industry. The industry median Days Sales Outstanding is 65.25. 4DMedical's value of 115.15 is 76.5% above this benchmark. Historically, 4DMedical's own Days Sales Outstanding has ranged from 77.38 to 1,766.11 over the past decade. While the company's 10-year median is 136.76 vs. the industry median of 65.25, 4DMedical has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Medical Devices & Instruments company?
The median Days Sales Outstanding among Medical Devices & Instruments companies is 65.25, based on 810 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. 4DMedical's current Days Sales Outstanding of 115.15 is 76.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on 4DMedical and its competitors. For the Medical Devices & Instruments industry, the median Days Sales Outstanding is 65.25 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. 4DMedical's current Days Sales Outstanding is 115.15, which is 16% below median its own 10-year median of 136.76. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 4DMedical stock overvalued right now?
Based on GuruFocus' analysis, 4DMedical (ASX:4DX) is currently considered Significantly Overvalued. The stock's GF Value™ is A$2.34, compared to a current price of A$3.44 — trading 47% above its estimated fair value. The current Days Sales Outstanding is 115.15, which is 16% below median its 10-year median of 136.76 and 76.5% above the Medical Devices & Instruments industry median of 65.25. 4DMedical's overall GF Score™ is 71/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For 4DMedical (ASX:4DX), the current Days Sales Outstanding is 115.15 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is 4DMedical (ASX:4DX) Overvalued in 2026?
Based on GuruFocus' analysis, 4DMedical stock appears to be overvalued.
The current stock price of A$3.44 is trading 47% above its estimated GF Value™ of A$2.34.
GuruFocus considers 4DMedical to be Significantly Overvalued.
Key valuation signals for ASX:4DX:
Days Sales Outstanding: 115.15 (16% below median its 10-year median of 136.76)
GF Value™: A$2.34 vs. price of A$3.44 (47% above fair value)
Industry Position: 76.5% above the Medical Devices & Instruments median (#675 of 810)
No single metric tells the full story. See the ASX:4DX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
4DMedical Ltd is a company focused on medical research technology and the development of a non-invasive respiratory imaging solution using four-dimensional imaging. The four-dimensional lung imaging technology utilizes mathematical models and algorithms to convert X-ray scans into quantitative data, aiding physicians in managing patients with respiratory and lung diseases.
71GF Score
Get the complete analysis for ASX:4DX
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASX:4DX has been successfully added to your 
